Incidence and mortality of prostate cancer and their relationship with the Human Development Index worldwide.
BACKGROUND
The aim of this study was to evaluate the incidence and mortality of prostate cancer and their relationship with the Human Development Index (HDI) and its components in Asia in 2012.


METHODS
This study was an ecological study conducted based on the GLOBOCAN project of the World Health Organization. The correlation between standardized incidence rate (SIR) and standardized mortality rate (SMR) of prostate cancer with HDI and its components was assessed using SPSS Inc Version 18.0 (Chicago).


RESULTS
There were 1,094,916 incident cases of prostate cancer and 307,481 deaths recorded in 2012 worldwide. SIR and SMR due to HDI were 72 and 9.7 in very high human development regions, 37.5 and 12.9 in high human development regions, 7 and 3.7 in medium human development regions, and 14.9 and 12.1 in low human development regions per 100,000 people, respectively. A positive correlation of 0.475 was seen between SIR of prostate cancer and HDI (P ≤ 0.001). Also, a negative correlation of 0.160 was seen between SMR of prostate cancer and HDI (P = 0.032).


CONCLUSIONS
The incidence of prostate cancer is high in countries with higher development. A positive correlation was observed between the SIR of prostate cancer and the HDI and its components, such as life expectancy at birth, mean years of schooling, and the gross national income per capita. In addition, there was a negative correlation between SMR and HDI.
Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
S
S
Hassanipour-Azgomi
Department of Social Medicine, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Abdollah
A
Mohammadian-Hafshejani
Department of Epidemiology & Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Mahshid
M
Ghoncheh
Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Farhad
F
Towhidi
Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Saeid
S
Jamehshorani
Zabol University of Medical Sciences, Zabol, Iran; Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Hamid
H
Salehiniya
Development; Incidence; Mortality; Prostate cancer
Int J Cancer. 2015 Mar 1;136(5):E359-86
25220842
J Clin Oncol. 2016 Jan 1;34(1):6-13
26578608
Cancer. 2014 May 1;120(9):1290-314
24343171
Prev Med. 2016 Jan;82:83-91
26582208
World J Urol. 2015 Nov;33(11):1677-87
25698456
Asian Pac J Cancer Prev. 2016;17 (2):839-43
26925689
Asian Pac J Cancer Prev. 2015;16(13):5137-41
26225642
Urology. 1986 Dec;28(6):472-9
2431533
N Engl J Med. 2012 Mar 15;366(11):981-90
22417251
Lancet Oncol. 2012 Aug;13(8):790-801
22658655
Asian Pac J Cancer Prev. 2016;17 (1):381-6
26838243
Ann Intern Med. 2013 May 21;158(10):709-17
23689764
Int J Cancer. 2015 Mar 1;136(5):E470-4
25236502
Prostate. 2015 May;75(7):758-63
25619191
J Natl Cancer Inst. 2002 Jul 3;94(13):981-90
12096083
Eur Urol. 2012 Jun;61(6):1079-92
22424666
Front Biosci. 2006 May 01;11:1388-413
16368524
Am J Epidemiol. 2002 Sep 1;156(5):471-82
12196317
Ann Intern Med. 2013 May 21;158(10):761-9
23567643
J Clin Oncol. 2007 Aug 20;25(24):3576-81
17704404
Epidemiol Rev. 2001;23 (1):173-80
11588845
J Natl Cancer Inst. 2009 Oct 7;101(19):1325-9
19720969
JAMA. 2015 Nov 17;314(19):2054-61
26575061
PLoS Med. 2006 Nov;3(11):e442
17132052
Cancer Epidemiol. 2012 Apr;36(2):e128-36
22018935
Eur Urol. 2013 Apr;63(4):693-701
22959192
CA Cancer J Clin. 2015 Mar;65(2):87-108
25651787
J Clin Oncol. 2012 Aug 20;30(24):3020-5
22802323
Am J Public Health. 1992 Jun;82(6):816-20
1585961
J Natl Cancer Inst. 2007 Sep 19;99(18):1384-94
17848670
Int J Cancer. 2013 Mar 1;132(5):1133-45
22752881
Int J Cancer. 2010 Dec 15;127(12):2893-917
21351269
Asian Pac J Cancer Prev. 2015;16(14):6081-7
26320499
Cancer Causes Control. 2009 May;20(4):417-35
19002764
Eur Urol. 2014 Jan;65(1):124-37
24207135
Prostate Int. 2015 Dec;3(4):135-40
26779461
Lancet. 2012 Nov 24;380(9856):1840-50
23079588
Asian Pac J Cancer Prev. 2015 ;16(18):8439-43
26745098
Asian Pac J Cancer Prev. 2015;16(16):7365-74
26514538
CA Cancer J Clin. 2013 Mar-Apr;63(2):88-105
23378235